维普中文期刊产品整合服务
63篇 您的检索式:作者名="Kohro"
    题名 作者 年代 出处 被引量
1Changes in serum cholesterol levels determine future risk of cardiovascular events in patients with acute coronary syndrome in the Japanese Coronary Artery Disease (JCAD) Study显示文摘Shota Fukuda Kenei Shimada Masatoshi Fujita Minoru Yoshiyama Junichi Yoshikawa Takahide Kohro Doubun Hayashi Tsutomu Yamazaki Ryozo Nagai 2013Journal of Cardiology2013,,6:1
2Intermittent pneumatic foot com- pression can activate blood fibrinolysis without changes in blood coag- ulability and ptatelet activation 显示文摘Kohro S Yamakage M Sato K 2005Acta Anaesthesiologica Scandi- navica2005,49,5:1
3Intermittent pneumatic foot compression can activate blood fibrinolysis without chan- ges in blood coagulability and platelet activation显示文摘Kohro S Yamakage M Sato K 2005Acta Anaesthesiol Scand2005,49,:1
4Surgical/tourniquet pain acce- lerates blood coagulability but not fibfinolysis 显示文摘Kohro S YamakageM Arakawa J 1998Br J Anaesth1998,80,4:1
5Detection of an up-regulation of a group of chemokine genes in murine cardiac allograft in the absence of interferon-gamma by means of DNA microarray显示文摘Saiura A Kohro T Yamamoto T 2002Transplantation2002,73,:1
6尼可地尔在日本冠状动脉疾病研究(JCAD)中对冠状动脉疾病患者心血管事件的影响显示文摘(接1月下)在观察研究中,对照组和治疗组之间的协变量不能进行调整,因此药物作用结果可能存在偏差。不过,采用包含药物使用情况的协变量作为条件概率的倾向得分分析,可在2实验组间形成良好的协变量平衡,并减少这种类型的偏差。对每个病人的倾向评分可表明服药的可能性,使用多重逻辑回归分析方法进行计算。所有的临床特征和除尼可地尔以外的药物都用到本计算中。Shigeo Horinaka Akihisa Yabe Hiroshi Yagi Toshihiko Ishimitsu Tsutomu Yamazaki Shinya Suzuki Takahide Kohro Ryozo Nagai 陈浩(译) 2016首都食品与医药2016,0,4:1
7Trends in antidiabetic prescription patterns in Japan from 2005 to 2011 显示文摘Kohro T Yamazaki T Sato H 2013Int Heart J2013,54,2:1
8Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction显示文摘Kawamura K Ishikawa K Wada Y Kimura S Matsumoto H Kohro T 2005Thromb Vasc Biol2005,25,1:1
9RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal),a randomized,doctor-oriented,multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese typ显示文摘Inazawa T Sakamoto K Kohro T 0,,01:1
10Intracellular mechanism of mitochondrial adenosine triphosphate-sensitive potassium channel activation with isoflurane显示文摘Nakae Y Kohro S Hogan QH 2003Anesth Analg2003,97,4:1
11A multicenter study design to assess the clinical usefulness of semi-automatic measure- ment of flow-mediated vasodilation of the brachia! artery 显示文摘Tomiyama H Kohro T Higashi Y 2012Int Heart J2012,53,3:1
12Intermittent pneumatic foot com- Pression can activate blood fibrinolysis without changes in blood eoag- Ulability and platelet activation 显示文摘Kohro S Yamakage M Sato K 2005Aeta Anaesthesiol Scand2005,49,:1
13In vitro effects of propofol on blood coagulability and fibtinolysis by the use of thromboelastograph technique显示文摘Kohro S Yamakage M Omote T 1999Acta Anaesthesiol Stand1999,43,2:1
14Intracellular mechanism of mitochondrial adenosine triphosphate-sensitive potassium channel activation with isoflurane显示文摘Nakae Y Kohro S Hogan QH 2003Anesth Analg2003,97,4:1
15Role of intracellular Ca2+ stores in the inhibitory effect of halothane on airway smooth muscle contraction显示文摘Yamakage M Kohro S Matsuzaki T Tsuchida H 1998Anesthesiology1998,89,1:1
16IntraceUular mechanism of mitochondrial adenosine triphosphate-sensitive potassium channel activation with isoflurane显示文摘NAKAE Y KOHRO S HOGAN QH 2003Anesth Analg2003,97,4:1
17The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID) 显示文摘YAMAZAKI T KOHRO T CHUJO M 2013Hypertens Res2013,36,:1
18Amel-ioration of hypertensive heart failure by amlodipine mayoccur via antioxidative effects 显示文摘HASEGAWA H TAKANO H KOHRO T 2006Hypertension Re-search2006,29,9:1
19Surgical tourni- quet pain accelerates blood coagulability but not fibrinoly- sis显示文摘Kohro S Yamakage M Arakawa J 1998Br J Anaesth1998,80,4:1
20尼可地尔在日本冠状动脉疾病研究(JCAD)中对冠状动脉疾病患者心血管事件的影响显示文摘(接2月下)此外,JCAD研究的平均随访期较IONA研究更长,两者分别为2.7和1.6年;I O N A中安慰剂组及J C A D中对照组的全因死亡率分别是129/2561例(5.0%)和156/2,558例(6.1%)。JCAD研究较IONA研究更高死亡率,其原因可能是IHD研究更加严格以及观测时间更长。IONA研究的亚组分析也表明,尼可地尔对治疗服用更多抗心绞痛药物的高危患者,或是对更高的加拿大心血管协会(CCS)功能状态评分患者,能起到最大降低绝对风险的作用。Shigeo Horinaka Akihisa Yabe Hiroshi Yagi Toshihiko Ishimitsu Tsutomu Yamazaki Shinya Suzuki Takahide Kohro RyozoNagai 陈浩(译) 2016首都食品与医药2016,23,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费